Evidence map›Paper›PMID 30179381›Full record

ArticleThe New England journal of medicine2018

Glucocorticoids with or without Fludrocortisone in Septic Shock.

Djillali Annane, Alain Renault, Eric Bellissant

Registry-linked trialAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in The New England journal of medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04540926 (Utility of Low Doses of Corticosteroids and Cyclosporine Combined With Enoxaparin, in Patients With COVID-19 Pneumonia at the ISSSTE Regional Hospital, Puebla, During the Contingency Period Due to the SARS-Cov2 Pandemic), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04540926 phase1 / phase2unknown statusnot on this mapstarted 2020, after this paper: background citation

Utility of Low Doses of Corticosteroids and Cyclosporine Combined With Enoxaparin, in Patients With COVID-19 Pneumonia at the ISSSTE Regional Hospital, Puebla, During the Contingency Period Due to the SARS-Cov2 Pandemic

TypeinterventionalSponsorInstituto de Seguridad y Servicios Sociales de los Trabajadores del EstadoRan2020 to 2020Enrolled200ConditionsCOVID 19 PneumoniaArmsCyclosporin A
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. The protective effect of rheumatic disease agents in COVID-19.Best practice & research. Clinical rheumatology · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Djillali AnnaneHôpital Raymond Poincaré, Garches, France djillali.annane@aphp.fr
Alain RenaultHôpital Pontchaillou, Rennes, France
Eric BellissantHôpital Pontchaillou, Rennes, France

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FludrocortisoneGlucocorticoidsAnti-Inflammatory AgentsHumansHydrocortisoneShock, SepticAnti-Inflammatory AgentsFludrocortisoneGlucocorticoidsHydrocortisone

Identifiers

PMID30179381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.